Injectable Drug Delivery
16 May 2018 - 17 May 2018
The SMi Group are thrilled to present the launch of Injectable Drug Delivery Conference 2018! The event is taking place in central London on 16th and 17th May 2018, with two pre-conference workshops occurring on 15th May 2018.
The Global Injectable Drug Delivery Market is expected to reach $789.7 billion USD by 2024, with a compound annual growth rate (CAGR) of 11.5% during the period of 2017 to 2024, according to Research Markets Reports. Therefore, this conference will aim to discuss the key developments in this field and the latest technological advancements.
Holiday Inn, Kensington Forum, London, UK
https://www.smi-online.co.uk/pharmaceuticals/uk/injectable-drug-delivery?utm_medium=www.injectable-drug-delivery.com&utm_source=P-248&utm_campaign=ddtdy
Highly Potent Active Pharmaceutical Ingredients (HPAPI)
21 May 2018 - 22 May 2018
SMi is delighted to announce its 2nd Annual Highly Potent Active Pharmaceutical Ingredients conference coming to London on the 21st - 22nd May 2018.
The global market for Highly Potent Active Pharmaceutical Ingredients is currently on a growth fast track, largely driven by its major use in oncology for cancer treatment and more often in the form of ADCs. Over a quarter of drugs worldwide now contain HPAPIs, as they have proven to be more effective than other APIs.
However, working with APIs high in potency and cytotoxicity comes with many regulations and requirements, and presents pharmaceutical companies with challenges such as handling, containment, cost and security questions.
This conference will cover many important and in-demand aspects of the HPAPI industry, creating a networking platform for industry professionals and key players to share their knowledge and find new innovative solutions.
Holiday Inn, Kensington Forum, London, UK
https://www.smi-online.co.uk/pharmaceuticals/uk/Highly-Potent-Active-Pharmaceutical-Ingredients?utm_medium=www.highlypotentapi.com&utm_source=P-250&utm_campaign=ddtdy
SMi’s Pain Therapeutics Conference
21 May 2018 - 22 May 2018
Each year SMi brings together decision makers and creative thinkers to unite and collectively shape and discuss the new breakthrough discoveries, innovations fuelling the future development of the Pain Therapeutics landscape.
We have worked hard to bring together an elite speaker panel to educate and inspire our delegates through the exploration of innovative approaches and novel targets in analgesic medicine.
Attendees of the Pain Therapeutics Conference will be able to network with industry experts from leading pharma companies, biotech and academics to name but a few.
2018 Highlights: Explore the possibilities of DNA-based, disease modifying treatments for painful diabetic neuropathy with ViroMed | Overcome the challenges of patient recruitment and the placebo response with Novartis | Learn how AstraZeneca and Eli Lilly are targeting ion channels to reduce pain | Get involved in round table discussions on chronic pain and depression, the opioid crisis, and alternatives to animal models | Listen to Centrexion, Amgen, Janssen, Nektar Therapeutics and Grunenthal discuss the current industry outlook | The upcoming Pain Therapeutics conference moves away from well discussed topics such as opioid dependence and animal models and focuses on the most exciting current research, opinions, novel targets and mechanisms and advances in the field of analgesic medicine.
Holiday Inn, Kensington Forum, London, UK
https://www.smi-online.co.uk/pharmaceuticals/uk/pain-therapeutics?utm_medium=www.pain-therapeutics.co.uk&utm_source=P-249&utm_campaign=pharmajournWL
ELRIG Discovery Technologies 2018
23 May 2018
ELRIG is pleased to invite you to the inaugural Discovery Technologies Meeting, to be held at Alderley Park, Macclesfield, UK, on 23rd May 2018. This exciting new ELRIG meeting will focus on the application of novel and emerging technologies that are reshaping the drug discovery paradigm.
For 2018, the conference will include two parallel sessions:
Advances in Mass Spectrometry
Advances in Organ-on-a-Chip Technologies
During this 1-day conference, researchers from top academic and industrial laboratories will discuss advances and case studies in these two rapid evolving research areas. In addition to the outstanding speaker program, you will have the opportunity to take part in vendor workshops, network at the exhibition and gain strategic insights into potential solutions for increasing the success of drug discovery and development in your organisation.
Alderley Park, Cheshire, UK
http://elrig.org/portfolio/discovery-technologies-2018/